Hypofractionated radiotherapy for breast cancer is becoming increasingly important. The scientific background of this development as well as the introduction of the simultaneous integrated boost to the primary tumor region in this context are discussed here.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677707 | PMC |
http://dx.doi.org/10.1159/000436951 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!